20 Sep 2017

Legionnaires’ disease in Dubai

Legionnaires’ disease reported in travellers visiting Dubai Legionnaires’ disease in Dubai

As of 1 August 2017, the European Centre for Disease Prevention and Control (ECDC) has reported 72 cases of Legionnaires’ disease (LD) in European residents returning from travel to Dubai, United Arab Emirates (UAE), including 34 cases in travellers from the United Kingdom (UK) since 1 October 2016 [1]. In comparison, the UK reported an average of ten cases for the corresponding period in 2014-15 and 2015-16 [2]. All those infected stayed in Dubai during the 2 -10 days before onset of symptoms [1]. All cases are laboratory confirmed.

Dubai is a popular destination for UK travellers, who represent the third largest group of visitors by nationality to Dubai; this may explain the higher number of LD cases in UK travellers compared to those reported in other European Union countries [1]. 

The UAE authorities have reported that risk assessment of accommodation sites and of possible high-risk sites such as cooling plants and major fountains has been undertaken in Dubai. To date, no single source of infection has been identified [1]. 

In response to the situation, Public Health England (PHE) and NaTHNaC have assessed the risk and published a Risk Assessment on Legionnaires’ disease associated with travel to Dubai advising that the overall risk to UK travellers to Dubai is low [2].

However, in the absence of a potential source(s) being identified and with limited information about the wider public health investigations being carried out in Dubai, PHE is unable to advise about the potential environmental source of these infections.

There may be an increased risk for those persons who are generally more likely to develop LD due to their older age (over 50 years), smoking or an underlying medical condition (such as immunosuppression or long term respiratory conditions). 

The World Health Organization has not advised against travel to Dubai [2].

All LD cases identified so far travelled to the city of Dubai. A small number of cases have travelled to Dubai in addition to other destinations both in and outside of UAE. There is currently insufficient information to suggest there is a risk in other areas of UAE [2]. 

About Legionnaires’ disease

LD is a bacterial infection of the lungs that usually develops into pneumonia. Most people catch it by breathing in small droplets of contaminated water suspended in air.

Symptoms include 'influenza-like' illness with muscle ache, tiredness, headache, dry cough, shortness of breath and fever. Sometimes diarrhoea occurs and confusion may develop. LD is more common in individuals aged over 50 years, smokers and anyone with pre-existing lung problems or chronic medical conditions.

Legionella bacteria are distributed widely in the environment. They can live in many types of water including, natural sources such as rivers and streams, artificial sources such as water-cooling towers, hot and cold water systems and spa pools. People can become exposed to the bacteria if the water systems are not properly maintained and become contaminated.

Advice for travellers

The risk of LD in travellers to Dubai is low. However, you may be at increased risk of LD if you:

  • are aged over 50 years
  • smoke
  • have an existing underlying medical condition e.g. a respiratory illness or immunosuppression

All travellers should be aware of LD symptoms, as described above. If you develop these symptoms within 10 days of departing from Dubai you should get medical attention, specifying where you have travelled. This will assist the healthcare professional to make an appropriate assessment of your symptoms and clinical condition, so that appropriate testing can be undertaken. If you develop these symptoms while in Dubai, you should seek medical attention locally, as directed by your travel insurance provider [2].

Advice for health professionals

For travellers with clinical or radiological evidence of pneumonia and a travel history to Dubai in the 2 - 10 days preceding the onset of their symptoms, LD testing should be considered. A urinary antigen test or a legionella PCR test on a lower respiratory specimen may be conducted for an initial diagnosis to be made.

Information for health professionals managing individuals with LD identified following local microbiological testing is available from PHE. All cases of LD (regardless of travel history) should be reported to the local health protection team (or equivalent in devolved administrations).


Ebola Virus Disease (EVD) in Democratic Republic of congo with update to Tanzania

The Ebola virus disease (EVD) outbreak continues in eastern Democratic Republic of Congo (DRC) Read more

Country-specific cholera recommendations 2019

NaTHNaC has updated the country-specific recommendations for cholera Read more

Updated guidelines for malaria prevention in travellers from the UK: 2019

Public Health England (PHE) Advisory Committee on Malaria Prevention (ACMP) has published updated malaria guidelines Read more

Nigeria: yellow fever outbreak

An outbreak of yellow fever has been confirmed in several states in Nigeria Read more

Public Health England updated vaccine incident guidance

PHE have published updated guidance on responding to errors in vaccine storage, handling or administration Read more
Back to Top